Results 21 to 30 of about 11,104 (231)

Digitoxin synergizes with sorafenib to inhibit hepatocelluar carcinoma cell growth without inhibiting cell migration.

open access: bronzeMolecular Medicine Reports, 2017
Yijun Xiao   +10 more
semanticscholar   +3 more sources

Digitoxin Affects Metabolism, ROS Production and Proliferation in Pancreatic Cancer Cells Differently Depending on the Cell Phenotype

open access: yesInternational Journal of Molecular Sciences, 2022
Digitoxin has repeatedly shown to have negative effects on cancer cell viability; however, the actual mechanism is still unknown. In this study, we investigated the effects of digitoxin (1–100 nM) in four pancreatic cancer cell lines, BxPC-3, CFPAC-1 ...
H. Lindholm   +2 more
semanticscholar   +1 more source

Clinical Implementation of Pharmacogenomics and Drug-Drug Interaction Screening in a German Academic Teaching Hospital and Outpatient Follow-Up. [PDF]

open access: yesClin Pharmacol Ther
Overview of the implemented pharmacogenomics (PGx) process in clinical routine at the Robert Bosch Hospital: from patient enrollment via the hospital information system, DNA detection using a customized TaqMan OpenArray panel and qPCR for CNV assessment, to clinical translation of genotyping results into PGx guideline‐based recommendations using a ...
Tremmel R   +13 more
europepmc   +2 more sources

Short term protective effect of digitoxin in sepsis-induced acute lung injury

open access: yesBiocell (Mendoza), 2022
Purpose: Digitoxin is a cardiac glycoside used in the treatment of heart failure. Inspired by its known antiinflammatory effect, this study aims to investigate the effect of digoxin in a sepsis model and to bring to light its effect and underlying ...
Ejder Saylav Bora   +6 more
semanticscholar   +1 more source

Transforming Growth Factor-β Pathway: Biological Functions and Therapeutic Targets. [PDF]

open access: yesMedComm (2020)
Natural compounds modulate the TGF‐β pathway, which acts as both a tumor suppressor and promoter during cancer progression. Agents such as ginsenosides, halofuginone, and EGCG influence cell proliferation, apoptosis, and angiogenesis. These bioactive molecules may complement standard therapies, highlighting the need for advanced formulations ...
Mekky RH   +9 more
europepmc   +2 more sources

Na+/K+‑ATPase subunit α3 expression is associated with the efficacy of digitoxin treatment in pancreatic cancer cells

open access: yesMedicine International, 2022
The alpha subunits (ATP1A1-3) of Na+/K+-ATPase binds digitoxin with varying affinity. The expression levels of these subunits dictate the anticancer effects of digitoxin.
H. Lindholm   +2 more
semanticscholar   +1 more source

Repurposing Cardiac Glycosides: Drugs for Heart Failure Surmounting Viruses

open access: yesMolecules, 2021
Drug repositioning is a successful approach in medicinal research. It significantly simplifies the long-term process of clinical drug evaluation, since the drug being tested has already been approved for another condition.
Jan Škubník   +3 more
doaj   +1 more source

Quo vadis Cardiac Glycoside Research?

open access: yesToxins, 2021
Cardiac glycosides (CGs), toxins well-known for numerous human and cattle poisoning, are natural compounds, the biosynthesis of which occurs in various plants and animals as a self-protective mechanism to prevent grazing and predation.
Jiří Bejček   +3 more
doaj   +1 more source

Na+/K+-ATPase Revisited: On Its Mechanism of Action, Role in Cancer, and Activity Modulation

open access: yesMolecules, 2021
Maintenance of Na+ and K+ gradients across the cell plasma membrane is an essential process for mammalian cell survival. An enzyme responsible for this process, sodium-potassium ATPase (NKA), has been currently extensively studied as a potential ...
Jiří Bejček   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy